Big Pharma Sharma
Big Pharma Sharma12+ year BioPharma strategy pro, facetiously named "Big Pharma Sharma". Delivering weekly insights, analyses, and takes here from an insider's perspective.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 61 | Subscribers | Read | bigpharmasharma.substack.com |
Curious about how many subscribers Big Pharma Sharma has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #244 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
ASH Part 2: Anito-cel is off to the races, but will it be fast enough to catch-up to Cilta-cel?
Arcellx presented Phase 2 pivotal iMMagine-1 data for anito-cel, their BCMA-targeted CAR-T for 5L+ relapsed/refractory multiple myeloma (RRMM), at ASH 2024.
ASH 2024 | Part 1: Miltenyi and Galapagos Aim Big in CAR-T, but Gaps Remain
It’s time for the annual ASH meeting, always a showcase for cutting-edge clinical data in competitive areas like blood cancers and hemoglobinopathies.
Two things I think coming out of SITC 2024
SITC 2024 brought forward some fascinating data, highlighting both the strides we’re making in immuno-oncology and the hurdles that remain.
Flipping the Script on Failed Immuno-Oncology Targets: The Case for “Inverse-I/O” in Autoimmune Diseases
Since the success of PD-(L)1 therapies, immuno-oncology (I/O) has been a hotbed of activity, with companies scrambling to find the next blockbuster target.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
BioPharma strategy pro with 12+ years of experience. Helped big & small companies make successful strategy decisions. Writing insightful analyses on topics of interest here. Hope to work with you in future. Please reach out.
Frequently Asked Questions
How can I access the email archive for Big Pharma Sharma?
You can find recent issues that have been published by Big Pharma Sharma on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Big Pharma Sharma have?
To see how many people subscribe to Big Pharma Sharma, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Big Pharma Sharma?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Big Pharma Sharma as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Big Pharma Sharma?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Big Pharma Sharma using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Big Pharma Sharma?
Scroll up to where it says Similar Newsletters to see other publications like Big Pharma Sharma. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Big Pharma Sharma?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.